U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H29NO2
Molecular Weight 243.3856
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAURIC MONOETHANOLAMIDE

SMILES

CCCCCCCCCCCC(=O)NCCO

InChI

InChIKey=QZXSMBBFBXPQHI-UHFFFAOYSA-N
InChI=1S/C14H29NO2/c1-2-3-4-5-6-7-8-9-10-11-14(17)15-12-13-16/h16H,2-13H2,1H3,(H,15,17)

HIDE SMILES / InChI

Approval Year

2016
495
PubMed

PubMed

TitleDatePubMed
Effect of head groups on the phase transitions in Gibbs adsorption layers at the air-water interface.
2010 Aug 1
Lauroylethanolamide is a potent competitive inhibitor of lipoxygenase activity.
2010 Jul 16
Patents

Patents

JP2003524046A
1
Name Type Language
LAURIC MONOETHANOLAMIDE
Common Name English
LAURIC ACID MONOETHANOLAMIDE
Common Name English
LAURAMIDE MEA
INCI  
INCI  
Official Name English
DODECANAMIDE, N-(2-HYDROXYETHYL)-
Systematic Name English
LAURAMIDE MONOETHANOLAMIDE
Common Name English
MONOETHANOLAMINE LAURIC ACID AMIDE
Systematic Name English
N-(2-HYDROXYETHYL)LAURAMIDE
Systematic Name English
N-(2-HYDROXYETHYL)DODECANAMIDE [HSDB]
Common Name English
LAURYLETHANOLAMIDE
Common Name English
LAURAMIDE MEA [INCI]
Common Name English
LAUROYL MONOETHANOLAMIDE
Common Name English
Code System Code Type Description
DAILYMED
098P2IGT76
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
FDA UNII
098P2IGT76
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
ECHA (EC/EINECS)
205-560-1
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
SMS_ID
100000165886
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
EVMPD
SUB179703
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
PUBCHEM
8899
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
CHEBI
85263
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
CAS
142-78-9
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
EPA CompTox
DTXSID5025493
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
RXCUI
1855084
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
HSDB
5644
Created by admin on Fri Dec 15 15:35:44 GMT 2023 , Edited by admin on Fri Dec 15 15:35:44 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966